Drugs / Infusion of CD34 selected hematopoietic stem cells
Infusion of CD34 selected hematopoietic stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06047886 | Apr 2025 → Oct 2029 expected | acute myeloid leukemia, chronic myeloid leukemia, lymphoma, myelodysplastic syndrome +1 | University of Alabama at Birmingham | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infusion of CD34 selected hematopoietic stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06047886 ↗ |
| Modality | Cell therapy | “CD34 selected hematopoietic stem cell infusion” NCT06047886 ↗ |